Fusion Antibodies (FAB) Insider Trading & Ownership GBX 8 -1.00 (-11.11%) As of 06:21 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies (LON:FAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.39%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£15.79KNumber OfInsiders Selling(Last 12 Months)0 Get FAB Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FAB Insider Buying and Selling by Quarter Fusion Antibodies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/6/2025Adrian KinkaidInsiderBuy100,000GBX 6£6,00010/16/2024Adrian KinkaidInsiderBuy83,728GBX 4£3,349.129/9/2024Richard John BuickInsiderBuy94,825GBX 3£2,844.759/4/2024Adrian KinkaidInsiderBuy120,000GBX 3£3,600 (Data available from 1/1/2013 forward) FAB Insider Trading Activity - Frequently Asked Questions Who is on Fusion Antibodies' Insider Roster? The list of insiders at Fusion Antibodies includes Adrian Kinkaid, Richard John Buick, Simon Gordon Douglas, and Sonya Maria Ferguson. Learn more on insiders at FAB. What percentage of Fusion Antibodies stock is owned by insiders? 11.39% of Fusion Antibodies stock is owned by insiders. Learn more on FAB's insider holdings. Which Fusion Antibodies insiders have been buying company stock? The following insiders have purchased FAB shares in the last 24 months: Adrian Kinkaid (£12,949.12), Richard John Buick (£2,844.75), and Simon Gordon Douglas (£9,528.25). How much insider buying is happening at Fusion Antibodies? Insiders have purchased a total of 649,118 FAB shares in the last 24 months for a total of £25,322.12 bought. Fusion Antibodies Key ExecutivesDr. Adrian Robert Kinkaid Ph.D. (Age 57)CEO & Director Compensation: $183.49kDr. Richard John Buick Ph.D. (Age 48)Chief Scientific Officer & Director Compensation: $127kProf. Jim JohnstonFounderMr. Stephen Barry Smyth (Age 50)Company Secretary, Interim CFO & Director Ms. Nicola HamiltonOperations ManagerDr. Paul Gerard Kerr (Age 51)Consultant Compensation: $180.38k More Insider Trading Tools from MarketBeat Related Companies SAR Insider Transactions AREC Insider Transactions POLB Insider Transactions IXI Insider Transactions OBD Insider Transactions DEST Insider Transactions ROQ Insider Transactions ONC Insider Transactions GNS Insider Transactions ONT Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (LON:FAB) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
